Turn drug-injury searches into signed cases.

Our pricing is public and simple. Google Ads management is 10% of your ad budget with a $600/month minimum, and there's no markup on ad spend — your whole budget goes to Google. SEO is $50 per page, starting at 10 pages a month. Custom websites are eight one-time packages from $1,500 to $20,000+ (details at /websites). Setup is $0, everything is month-to-month with no contract, and a 30-day guarantee means if you're not happy, you don't pay. Tell us about your firm and we'll send exact numbers in a free proposal within one business day.

If your intake is full of people who don't qualify, a recall spike came and went without you seeing it, or you can't say which litigation actually paid for last month's marketing, an agency pays for itself. We build the pages, compliant ads, SEO, and screening that keep qualified dangerous-drug claimants coming in — so your team spends time on cases, not on marketing. Already sourcing enough qualified claimants on your own? You may not need one yet.

It runs every channel that produces signed pharmaceutical-injury cases. SearchPod builds your claim pages and brand, runs bar-compliant Google Ads on the specific drugs and injuries you're pursuing, wins local and AI search, and automates intake screening, follow-up, and reviews — one connected system, with one team accountable for cost per signed case.

Pick one that understands pharmaceutical litigation specifically: screening built into every page and ad, tracking that ties every claimant to a signed case instead of a raw lead, bar-compliant campaigns, and you keeping ownership of your pages, ad accounts, and claimant data. Skip generalists who treat a drug litigation like any other lead-gen funnel. Ask how they screen, and how fast they can launch a page for a new litigation.

Google Ads can produce screened claimants within the first couple of weeks — which matters when a recall creates a short window of search interest. SEO, AI search, and reviews build more slowly, compounding over 3–6 months into claimant flow you don't pay per click for. Running both together from day one is the fastest way to catch a fast-moving litigation.

Your pages, ads, SEO, AI search, intake, and reviews run as one connected system, not five vendors pointing fingers at each other. Screening is built into every page and ad from day one, campaigns stay bar-compliant, and every signed case is tracked to its true cost. Our pricing is public — real starting prices on our pricing page. Month-to-month, no lock-in, and you own your pages, ad accounts, and claimant data.

Yes — screening is the whole point. We build the eligibility questions for your exact drug, diagnosis, and duration of use directly into your landing pages and campaigns, so claimants are pre-qualified before they ever reach your intake team. That keeps staff focused on people who actually fit your litigation.

Yes. State bar rules restrict outcome guarantees and certain testimonials, and platforms have their own review process for legal and health-related ads, so every page, ad, and review request is built to stay inside those rules — so your firm can compete for this vertical without putting your license or ad accounts at risk.

Yes — call tracking, form tracking, and conversion tracking are set up from day one, attributed by drug and litigation, so you'll know your true cost per signed case and which campaigns are worth scaling. Cost per lead alone hides the real answer; we measure what actually signs.

Yes. Your forms, call tracking, and campaigns plug into your intake workflow and case-management system — Litify, Filevine, Clio, or whatever you run — with fast routing so a qualified claimant reaches your team while the litigation window is still open.

100%. Your pages, brand assets, ad accounts, and claimant data belong to your firm — every claim page for every litigation. Month-to-month with no lock-in: if we ever part ways, the whole system leaves with you.

Most claim-specific landing pages and campaigns launch in about 2–4 weeks, depending on eligibility criteria and how quickly we get content and compliance sign-off. When a new warning or recall is moving fast, we compress that schedule — and you'll have a clear timeline from day one.